Consistent with previous studies, we found that the expression of CHST4 mRNA was higher in cholangiocarcinoma (24), colon adenocarcinoma (18), and gastric adenocarcinoma (22), and we partially verified this conclusion immunohistochemically. This evidence concerns the gene CHST4 and gastric adenocarcinoma.